1. Home
  2. /
  3. Venture Capital
  4. /
  5. MRM Health Initiates Clinical...

News / Venture Capital

MRM Health Initiates Clinical Research in Parkinson’s Disease

20 February 2024
MRM Health, a clinical-stage biopharmaceutical company, announced today that it has received regulatory and ethics committee approval to start an observational, cross-sectional clinical trial to study the role of the small intestinal microbiome in Parkinson’s Disease (PD) and to identify PD-specific microbial and metabolic fingerprints in small intestinal fluid and blood.


Press Release

Related News